Cargando…
Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors
OBJECTIVES: To summarize data supporting the effects of antidiabetes agents on glucose control and cardiovascular risk factors in patients with type 2 diabetes. METHODS: Studies reporting on the effects of antidiabetes agents on glycemic control, body weight, lipid levels, and blood pressure paramet...
Autores principales: | Kurukulasuriya, L Romayne, Sowers, James R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940872/ https://www.ncbi.nlm.nih.gov/pubmed/20804556 http://dx.doi.org/10.1186/1475-2840-9-45 |
Ejemplares similares
-
HbA(1c): The lower the better?
por: Araki, Eiichi, et al.
Publicado: (2011) -
Effects of nutrition therapy on HbA1c and cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes
por: Mottalib, Adham, et al.
Publicado: (2018) -
Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022) -
HbA(1c) and Lower-Extremity Amputation Risk in Low-Income Patients With Diabetes
por: Zhao, Wenhui, et al.
Publicado: (2013) -
Beyond HbA(1c): Environmental Risk Factors for Diabetic Retinopathy
por: Nwanyanwu, Kristen Harris, et al.
Publicado: (2015)